Accretion Nutraveda IPO

About Accretion Nutraveda Company

Accretion Nutraveda, founded in 2021 in Ahmedabad, operates as a healthcare-focused Contract Development and Manufacturing Organization specializing in Ayurvedic and nutraceutical products across dosage forms such as tablets, capsules, oral liquids, powders, external preparations, and oils. The business has evolved from a broader healthcare division active since 2012 into a modern Ayurveda and nutraceutical manufacturer and exporter serving both domestic and international markets including the USA, Sri Lanka, and Singapore, with a portfolio spanning digestive, respiratory, liver, bone and joint, women’s health, paediatric, skin and hair, urinary, and general health and wellness segments. Its core focus is CDMO and private-label manufacturing for herbal and nutritional supplements, leveraging a GMP-compliant, WHO-GMP, ISO, FSSAI, Halal and Ayush-certified facility in Gujarat to deliver end-to-end solutions from formulation development through manufacturing, packaging, and quality testing. Key areas of expertise include integrating classical Ayurvedic principles with modern nutraceutical science, standardized herbal extracts, and specialized processes such as traditional decoction-based syrups, Kshir Paak oil preparation, and multiple packaging technologies, supported by in-house physico-chemical, instrumental, and microbiology labs for stringent quality assurance. Distinct strengths lie in its value-for-money product philosophy, technologically advanced plant and processes, and long-standing relationships with both large corporate clients and niche brands, underpinned by a “Growing Together” approach that emphasizes customer satisfaction, innovation, and reliable partnership to address regulatory, quality, and scalability challenges in the herbal and nutritional supplements industry.